Search Results - "Groark, James G."

EMBRACE: One Small Story in Lupus—One Giant Challenge in Clinical Trials by Sheikh, Saira Z., Englund, Tessa R., Burriss, Susan W., Bull, Jonca, Harry, Anya, Groark, James G., Hall, Ashley M., Miller, Michelle, Roth, David A.

“…Clinical trials of novel therapeutics in the United States have not been adequately representative of diverse populations, particularly racial and ethnic…”
Get full text

Clinical response beyond the Systemic Lupus Erythematosus Responder Index: post-hoc analysis of the BLISS-SC study by van Vollenhoven, Ronald F, Stohl, William, Furie, Richard A, Fox, Norma Lynn, Groark, James G, Bass, Damon, Kurtinecz, Milena, Pobiner, Bonnie F, Eastman, William J, Gonzalez‑Rivera, Tania, Gordon, David

“…ObjectiveThe Systemic Lupus Erythematosus (SLE) Responder Index (SRI), developed as a primary outcome measure for use in clinical trials, captures improvement…”
Get full text

Phase III/IV, Randomized, Fifty‐Two–Week Study of the Efficacy and Safety of Belimumab in Patients of Black African Ancestry With Systemic Lupus Erythematosus by Ginzler, Ellen, Guedes Barbosa, Luiz Sergio, D'Cruz, David, Furie, Richard, Maksimowicz‐McKinnon, Kathleen, Oates, James, Santiago, Mittermayer Barreto, Saxena, Amit, Sheikh, Saira, Bass, Damon L., Burriss, Susan W., Gilbride, Jennifer A., Groark, James G., Miller, Michelle, Pierce, Amy, Roth, David A., Ji, Beulah

“…Objective Enrollment of patients of Black African ancestry with systemic lupus erythematosus (SLE) in phase II and phase III of the belimumab trials was not…”
Get full text